# Clinical Trial to Evaluate Two Guidelines for the Administration of Ibuprofen in the Treatment of Persistent Ductus Arteriosus Eco-guided: Impact in the Intestinal Prognosis

> **NCT04282941** · PHASE3 · UNKNOWN · sponsor: **Instituto de Investigación Hospital Universitario La Paz** · enrollment: 180 (estimated)

## Conditions studied

- Persistent Ductus Arteriosus

## Interventions

- **DRUG:** Ibuprofen in continuous (24 hours) iv infusion and EchoG
- **DRUG:** IV bolus Ibuprofen slow (15 minutes) and EchoG

## Key facts

- **NCT ID:** NCT04282941
- **Lead sponsor:** Instituto de Investigación Hospital Universitario La Paz
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-20
- **Primary completion:** 2020-01-30
- **Final completion:** 2020-11-30
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2020-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04282941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04282941, "Clinical Trial to Evaluate Two Guidelines for the Administration of Ibuprofen in the Treatment of Persistent Ductus Arteriosus Eco-guided: Impact in the Intestinal Prognosis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04282941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*